Risk factors for community-associated multidrug-resistant Pseudomonas aeruginosa in veterans with spinal cord injury and disorder: a retrospective cohort study

Study design: Retrospective cohort study Objectives: To identify independent risk factors associated with community-associated multidrug-resistant Psedomonas aeruginosa (MDRPA) in a population of veterans with spinal cord injury and disorders (SCI/D). Setting: A total of 127 Veterans Affairs healthc...

Full description

Saved in:
Bibliographic Details
Published in:Spinal cord Vol. 55; no. 7; pp. 687 - 691
Main Authors: Kale, I O, Fitzpatrick, M A, Suda, K J, Burns, S P, Poggensee, L, Ramanathan, S, Sabzwari, R, Evans, C T
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-07-2017
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Study design: Retrospective cohort study Objectives: To identify independent risk factors associated with community-associated multidrug-resistant Psedomonas aeruginosa (MDRPA) in a population of veterans with spinal cord injury and disorders (SCI/D). Setting: A total of 127 Veterans Affairs healthcare facilities. Methods: Laboratory results from 1 January 2012 to 31 December 2013 were collected, and MDRPA cultures were compared with non-MDRPA cultures. Results: One thousand four hundred forty-one cultures were collected from Veterans with SCI/D, including 227 cultures with MDRPA isolates. Characteristics associated with an increased odds of MDRPA include age 50–64 (adjusted odds ratio (aOR)=1.80, 95% confidence interval (CI)=1.13–2.87), MDRPA culture in the past 365 days (aOR=9.12, 95% CI=5.88–14.15) and carbapenem exposure in the past 90 days (aOR=2.56, 95% CI=1.35–4.87). In contrast, paraplegia was associated with a 53% decreased odds of MDRPA compared with those with tetraplegia (aOR=0.47, 95% CI=0.32–0.69). Conclusions: Risk factors for community-associated MDRPA include prior history of MDRPA and exposure to carbapenems. Awareness of these factors is important for targeted prevention and treatment of MDRPA in patients with SCI/D.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1362-4393
1476-5624
DOI:10.1038/sc.2017.7